Skip to content
healthcare.dev

MiraLAX

NDC 11523-4357, Polyethylene Glycol 3350, powder, for solution, from Bayer HealthCare LLC..

Product NDC
11523-4357
Status
Listed
Labeler
Bayer HealthCare LLC.
Dosage form
POWDER, FOR SOLUTION
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
NDA
Application
NDA022015
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/11523-4357 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • POLYETHYLENE GLYCOL 335017 g/17g

Pharmacologic classes

Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]

Package NDCNDC-11Package
11523-4357-2115234357022 CARTON in 1 CARTON (11523-4357-2) / 20 PACKET in 1 CARTON / 17 g in 1 PACKET
11523-4357-3115234357032 BOTTLE, PLASTIC in 1 PACKAGE, COMBINATION (11523-4357-3) / 578 g in 1 BOTTLE, PLASTIC
11523-4357-51152343570524 PACKET in 1 CARTON (11523-4357-5) / 17 g in 1 PACKET

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 11523-4357 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/11523-4357 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 11523-4357. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.